↓ Skip to main content

American Association for Cancer Research

Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
24 Mendeley
Title
Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations
Published in
Cancer Epidemiology, Biomarkers & Prevention, January 2020
DOI 10.1158/1055-9965.epi-19-0245
Pubmed ID
Authors

Christina D Williams, Naomi Alpert, Thomas S Redding, A Jasmine Bullard, Raja M Flores, Michael J Kelley, Emanuela Taioli

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 13%
Researcher 3 13%
Librarian 1 4%
Unspecified 1 4%
Student > Ph. D. Student 1 4%
Other 3 13%
Unknown 12 50%
Readers by discipline Count As %
Medicine and Dentistry 6 25%
Social Sciences 1 4%
Unspecified 1 4%
Unknown 16 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2023.
All research outputs
#2,312,309
of 25,387,668 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#690
of 4,850 outputs
Outputs of similar age
#55,178
of 473,172 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#11
of 87 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,850 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,172 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.